---
title: "NAUT: First revenue achieved and net loss narrowed as proteoform assay development accelerates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294046894.md"
description: "First revenue recognized in Q2 2026 from grants and early access services, with net loss narrowing to $14.5 million year-over-year. Resource reallocation accelerates proteoform assay development, while Voyager Platform and expanded portfolio remain on track for 2027 launches.Original document: Nautilus Biotechnology, Inc. [NAUT] SEC 8-K Current Report — Jul. 28 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-28T10:05:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294046894.md)
  - [en](https://longbridge.com/en/news/294046894.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294046894.md)
generator: "portal-rs"
---

# NAUT: First revenue achieved and net loss narrowed as proteoform assay development accelerates

First revenue recognized in Q2 2026 from grants and early access services, with net loss narrowing to $14.5 million year-over-year. Resource reallocation accelerates proteoform assay development, while Voyager Platform and expanded portfolio remain on track for 2027 launches.

Original document: Nautilus Biotechnology, Inc. \[NAUT\] SEC 8-K Current Report — Jul. 28 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [NAUT.US](https://longbridge.com/en/quote/NAUT.US.md)

## Related News & Research

- [Undervalued Penny Stocks To Consider In August 2026](https://longbridge.com/en/news/296816088.md)
- [Nautilus Biotechnology posts first revenue, Q2 net loss narrows](https://longbridge.com/en/news/294063687.md)
- [Canada Pension Plan Investment Board Purchases Shares of 10,218,400 Sana Biotechnology, Inc. $SANA](https://longbridge.com/en/news/297287120.md)
- [Maia Bio director Ramiro Guerrero acquires 1,794 common shares worth $2,386.02](https://longbridge.com/en/news/297040658.md)
- [Solas Capital Management LLC Purchases New Position in MAIA Biotechnology, Inc. $MAIA](https://longbridge.com/en/news/296899245.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**